Manufacturer
Esperion Therapeutics
- Products listed
- 2
- Molecules
- 2
- Therapy areas
- 1
Esperion Therapeutics is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 2 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Esperion Therapeutics, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Esperion Therapeutics products through licensed channels, with the documents your regulator needs.
Cardiology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Nexletol 180 mg tabletOral | Bempedoic acid | US FDA | Available on request |
| Nexlizet 180 mg/10 mg tabletOral | Bempedoic acid and Ezetimibe | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Esperion Therapeutics
Send a request for any of these products. We confirm the licensed source, documents and lead time.